Niagen Bioscience, Inc.
NASDAQNiagen Bioscience heads into the week with one of the most striking options sentiment reversals in the past year — call buyers have overwhelmed the market with an aggression that places the current read near the year's most bullish extreme. Options positioning has swung sharply in the bulls' favour. The put/call ratio collapsed to 0.24 by Tuesday, more than 2.4 standard deviations…
NAGE put/call ratio collapses to 0.25, hitting four standard deviations below the 20-day mean of 0.58—the lowest level in 52 weeks, signaling aggressive call buying and bullish sentiment as the stock rallies ahead of earnings May 6.
Snapshot as of 22 Jun 2026
Niagen Bioscience heads into the week with one of the most striking options sentiment reversals in the past year — call buyers have overwhelmed the market with an aggression that places the current read near the year's…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NAGE — free to start on ORTEX.
Sign up for free →Open NAGE on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live NAGE data →